Find the Right Lab for Your Genetic Testing
…for people with axonal CMT is lower than demyelinating CMT. What is the pattern of inheritance in the family? Are multiple family members affected? Are they in the same generation…
Our Research
The CMTA-STAR Initiative STAR, the CMTA’s research initiative, was created with one goal: to find treatments to slow, stop or reverse the progression of CMT. Working with investigators and scientists…
Español
What is CMT? Spanish Edition (14995 downloads ) What is CMT? Spanish Edition Flipbook…
STAR insert 2023
…discoveries. CRITICAL RESEARCH RESOURCES AND LEARNINGS • New rodent models of CMT have emerged as crucial testing resources for potential therapies covering CMT1A, CMT2A, CMT1X, CMT2E and CMT1B. The CMTA…
We Are Family
…Do it for our family. On behalf of the entire CMTA family, you have our sincere gratitude. Amy Gray, CMTA Chief Executive Officer, and Jeana Sweeney, CMTA Director of Development…
Getting Started
Register Your Event Contact your CMTA National Events Manager, Andi Cosby (andi@cmtausa.org), with the following information to have your event added to our website. Event Name – this must include…
Seattle Focus Group with Acceleron Pharma
We are pleased to announce another opportunity to get involved with the CMTA’s Patients as Partners in Research initiative! The goal of Patients as Partners in Research is to advance…
Cynthia Lawrence, Disney Princess and Athlete
…she tries to sew, knit and paint. She is a member of the South Florida CMTA Branch and moderator of the CMTAthletes Facebook group (www.facebook.com/groups/cmtathletes/). And she loves college football….
Acceleron Announces Topline Results from the Phase 2 Trial of ACE-083 in Patients with Charcot-Marie-Tooth Disease
…to the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, today announced that treatment with ACE-083 in patients with Charcot-Marie-Tooth disease (CMT) did not…
GeneDx Genetic Testing & Whole Exome Sequencing
…diagnoses in patients with CMT. Therefore, GeneDx offers a Core CMT panel, which targets these four most common genes. In addition, GeneDx offers other multigene panels based on a patient’s…